🧲 Hannah Joseph Hospital IPO – Live Snapshot
Price Band ₹67 – ₹70
GMP Today ₹0 (Unofficial)
Lot Size 1,500 Shares
Live Subscription 0.00x
➡️ Quick Updates: • GMP Today • Subscription Status
⚡ LIVE IPO UPDATE (Latest)
• Hannah Joseph Hospital IPO is witnessing muted grey market activity with GMP at ₹0.
• SME healthcare IPOs usually attract selective investor interest rather than aggressive oversubscription.
• Listing performance will depend mainly on subscription momentum in the last two days.
Insight: Unless subscription crosses 2x–4x overall, listing gains are expected to remain limited or flat.
IPO Snapshot (Complete Details)
| Issue Size | Approx ₹X.X Crore |
| Issue Type | Fresh Issue |
| Price Band | ₹67 – ₹70 |
| Lot Size | 1,500 Shares |
| Minimum Investment | ₹1,05,000 (Approx) |
| IPO Opens | 22 January 2026 |
| IPO Closes | 27 January 2026 |
| Listing Date | 30 January 2026 (Expected) |
| Exchange | BSE SME |
| Registrar | To be Updated |
IPO Reservation Structure
| Retail Investors | 35% |
| NII / HNI | 50% |
| QIB | 15% |
Financial Performance (₹ Crore)
| Metric | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | ₹54.90 | ₹63.63 | ₹77.90 |
| PAT | ₹1.01 | ₹4.07 | ₹7.21 |
| EBITDA Margin | 30.74% | 28.94% | 27.16% |
Key Valuation Metrics
| EPS (FY25) | ₹X.XX |
| Post-IPO P/E | ~XXx |
| ROE | ~XX% |
| Debt-to-Equity | ~X.X |
Use of IPO Proceeds
- Working capital requirements
- Hospital infrastructure expansion
- Operational and general corporate purposes
Strengths vs Risks
Strengths
- Stable healthcare demand
- Growing revenue and profitability
- Essential services sector
Risks
- High operational costs
- Regulatory compliance risk
- Limited scalability vs manufacturing SMEs
Risk–Reward Score (Fintech Model)
| Business Quality | Medium |
| Growth Visibility | Moderate |
| Valuation Comfort | Neutral |
| Listing Gain Probability | Low to Moderate |
| Overall Risk Level | High (SME IPO) |
Final Verdict
Hannah Joseph Hospital IPO is a moderate-risk SME healthcare issue. While fundamentals show stability, muted GMP and SME liquidity risk suggest limited listing upside unless subscription momentum improves sharply.
Disclaimer: This content is for educational purposes only. IPO investments involve market risks. Consult a SEBI-registered advisor before investing.
About The Author
